Clinical trials
Humans clinical trials
Below are recruiting humans clinical trials, each written for real people, not researchers. We’re tracking 1,228 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06798545Recruiting
Study of a new navigation system for pancreas EUS
This trial is testing a new navigation system to help doctors see the pancreas during an endoscopic ultrasound (EUS) exam. The system may make it easier to spot lesions or other problems in the pancreas.
StrasbourgAges 18 years+ - NCT07169318RecruitingPhase 1
Safety study of VNT-101 in healthy adults
This first-in-human study tests the safety of a new medicine called VNT-101. Healthy adults aged 18 to 59 who do not smoke and have no major health problems may be able to join. The goal is to see how the body handles the drug and if it is safe.
Overland Park, KansasAges 18–59 - NCT07166757RecruitingPhase 1/Phase 2
Study of XS411 for early-onset Parkinson's disease
This trial tests a new treatment called XS411 for people with early-onset Parkinson's disease (age 50 or younger at diagnosis). It is for those whose motor symptoms are not well controlled with standard medications and who may benefit from a neurosurgical procedure.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07173881Recruiting
Dairy product for mothers and breast milk health
This study tests whether a special dairy product for pregnant and breastfeeding women can change the makeup of their breast milk. It aims to see if it helps improve nutrition for both mother and baby.
La Plata, Buenos AiresAges 18 years+ - NCT07172165Enrolling by invitation
Improving detection of clot signals in brain ultrasound
This study focuses on improving how doctors classify tiny signals (called microembolic signals) from the brain, which can help detect stroke risk. Your recorded signals—if from a solid source, like a clot—will be reviewed by experts to develop better computer tools.
PortoAges 18 years+ - NCT07167849Recruiting
Digital help while waiting for therapy
This trial tests a brief digital program for people waiting for outpatient therapy. It aims to provide support during the wait and see if it helps improve mental health symptoms.
BernAges 18 years+ - NCT07171281Recruiting
Timing meals to improve blood sugar and heart health
This study tests whether eating at specific times of day can help control blood sugar and improve heart health in people with prediabetes or type 2 diabetes. It compares two different eating schedules to see which works better.
NuthetalAges 18–75 - NCT06490783Recruiting
Studying a smart technology system for healthy aging
This study tests a new technology system that uses sensors and artificial intelligence to support healthy aging. Researchers want to see if it can help older adults improve their well-being and stay healthy.
MessinaAges 60 years+ - NCT07160075RecruitingPhase 4
HIV prevention with PrEP for people on opioid therapy
This trial tests if daily PrEP medication can help prevent HIV in people receiving opioid replacement therapy. You must be HIV-negative and regularly attend your opioid treatment program to join.
Calgary, AlbertaAges 16 years+ - NCT07162584Recruiting
Oxytocin and human defensive responses
This study looks at how oxytocin—a natural hormone—affects your body's defensive reactions in changing situations. It may help researchers understand how our brains handle fear and safety.
Chengdu, SichuanAges 18–35 - NCT07163403RecruitingPhase 1
Preventing cancer in Lynch syndrome carriers with dendritic cell vaccine
This trial tests whether a personalized vaccine made from your own immune cells can help prevent cancer in people with Lynch syndrome. You must have no history of cancer and be willing to have regular colonoscopies.
Barcelona, BarcelonaAges 18 years+ - NCT07155993Enrolling by invitation
Long-term fasting and food reintroduction study
This study looks at what happens in your body during a long fast (5+ days) and when you start eating again. It may help you understand how fasting affects your health.
Überlingen, Baden-WurttembergAges 18–90 - NCT07160725RecruitingPhase 1/Phase 2
Testing a new drug for advanced solid tumors
This trial is testing a new drug (BMS-986517) for people with advanced solid tumors, including certain lung, head and neck, and breast cancers. The goal is to see if the drug is safe and effective.
Irvine, CaliforniaAges 18 years+ - NCT07161414RecruitingPhase 1
Study of rilvegostomig for advanced solid tumors
This study tests a new investigational drug, rilvegostomig, given as an injection under the skin. It is for people with advanced solid tumors that have not responded to or have progressed after standard treatments. The goal is to see how the drug behaves in the body and to assess its safety.
Huntersville, North CarolinaAges 18 years+ - NCT07147348RecruitingPhase 1/Phase 2
BNT3212 alone or with BNT327 for advanced solid tumors
This trial tests a new drug called BNT3212, either alone or combined with BNT327, in people with advanced solid tumors that have not gotten better with standard treatments. The goal is to find safe doses and see if the drugs can shrink tumors or slow their growth.
AdelaideAges 18 years+ - NCT03859050Recruiting
Study immune-cell changes after a controlled endotoxin exposure
This study tests how your lungs’ immune cells respond after a controlled exposure to endotoxin. It may help researchers understand and prevent harmful lung inflammation, even though it is a short, research-focused intervention.
Denver, ColoradoAges 18–50 - NCT07145697RecruitingPhase 4
EEG study of anesthesia and consciousness in epilepsy
This trial tests how anesthesia affects brain activity in people with drug-resistant epilepsy who need brain electrode monitoring. It may help us understand consciousness and improve anesthesia safety.
Guangzhou, GuangdongAges 3–65 - NCT07145489Recruiting
Infrared light therapy for seizures
This trial tests whether shining a special infrared light on the scalp can reduce seizures in adults with epilepsy that is not controlled by standard medications. You would receive the light treatments and keep a diary of your seizures.
Boston, MassachusettsAges 18 years+ - NCT07136922RecruitingPhase 1
Testing a new progesterone tablet for luteal phase issues
This trial tests a new progesterone tablet (Callavid) to see if it is safe and easy to use for women with a short or weak luteal phase (the time after ovulation). It may help support early pregnancy and reduce the risk of miscarriage.
CoventryAges 18–45 - NCT07136779RecruitingPhase 1/Phase 2
Study of VBC101 for advanced solid tumors
This trial tests a new drug called VBC101 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if VBC101 is safe and effective.
Grand Rapids, MichiganAges 18 years+ - NCT07143318RecruitingPhase 1
First-in-Human study of KLA578-1 for injection in healthy volunteers
This trial tests a new investigational drug for the first time in people. It will study how the drug is processed by the body in healthy volunteers. If you are a generally healthy adult, you may be able to help with this important early research.
Changsha, HunanAges 18–45 - NCT07142044RecruitingPhase 1/Phase 2
Testing EC5026 for Parkinson's disease
This study tests a new oral medication called EC5026 for Parkinson's disease. It aims to see if the drug is safe and if it might help control symptoms when added to your current levodopa treatment.
Sacramento, CaliforniaAges 50–80 - NCT07140614RecruitingPhase 1
Study of EDK060 for adults with CMT1A
This trial tests a new medicine called EDK060 for people with Charcot-Marie-Tooth disease type 1A (CMT1A). The study will check if the drug is safe and how the body processes it, with the goal of finding better treatments for this condition.
Ottawa, OntarioAges 18–60 - NCT07143539Recruiting
Early exercise rehab after hospital stay for pulmonary embolism
This study tests if starting a supervised exercise program early after a hospital stay for a blood clot in the lungs (pulmonary embolism) helps patients recover better and feel less breathless. It is for people at higher risk of ongoing symptoms after their clot.
AarauAges 18 years+
Hear when a new Humans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for humans?
- Yes. Clin2 currently lists 1,228 recruiting humans studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a humans trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a humans trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.